Case Study: When “Normal” B12 Is Not Normal, A Functional Gut, Methylation, and Nutrient Depletion Story

Patient Overview

Initials: P.M.
Age/Sex: 41-year-old female
Diet pattern: Lifelong vegetarian, strict vegan x 2 years
Time course: GI symptoms for about 2 years, diagnosed with iron deficiency anemia earlier this year (self-reported improvement on iron), new alopecia areata and diffuse hair shedding

Presenting Concerns and Goals

P.M. presented with:

• Poor digestion with intermittent abdominal pain, bloating, and irregular bowel patterns (alternating constipation and loose stools)
• Fatigue, brain fog, and reduced exercise tolerance
• Hair loss, including an alopecia areata patch
• History of anemia treated with iron prior to intake

P.M.’s primary goals were to:

• Identify the root cause of chronic digestive symptoms and normalize bowel patterns
• Restore energy, mood, and cognitive clarity
• Address hair loss
• Correct nutrient deficiencies while honoring her dietary preferences when possible

Key Laboratory Findings and Interpretation

Glycemic Markers

• Glucose: 87 (functional range 75 to 90)
• Hemoglobin A1c: 5.8 (functionally elevated)

Interpretation:
A1c is functionally elevated, but interpret with caution in the setting of recent iron deficiency or shifting red cell turnover, since A1c can be artifactually higher when iron deficiency is present. The next step is to pair A1c with fasting insulin, HOMA-IR, and ideally CGM or postprandial data once iron status is stable.

Nutrient Status

B12 and methylation-related markers

• Vitamin B12: 222 (very low from a functional interpretation)
• Serum methylmalonic acid (MMA): 645 (markedly elevated)
• Homocysteine: 18.2 (markedly elevated)

Interpretation:
This is a high-confidence pattern of functional B12 deficiency, even though serum B12 is technically in range. Elevated MMA reflects intracellular B12 insufficiency. Elevated homocysteine suggests impaired methylation capacity, often worsened by low B12, low folate, low B6, riboflavin insufficiency, or genetic vulnerability.

Folate status

• Urine FIGLU: 2.7 (elevated, upper range 2.2)

Interpretation:

Elevated FIGLU supports functional folate insufficiency. With P.M.’s methylation genetics (MTHFR C677T +/+), folate status becomes clinically relevant. Folate repletion should not be initiated in isolation when B12 is deficient, both should be addressed in a coordinated, monitored plan.

Vitamin D

• Vitamin D (25-OH): 9.7 (severe deficiency)

Interpretation:

This level is profoundly low and can contribute to fatigue, immune dysregulation, mood symptoms, and impaired hair cycling. Repletion is a priority and should be paired with magnesium support and follow-up testing.

Iron and hair-relevant markers

• Ferritin: 28 (low-normal, often suboptimal for hair regrowth)
• Hemoglobin: 12.5 (functionally low)

Interpretation:

Iron stores appear insufficient for hair resiliency in many women, particularly when paired with autoimmune-pattern hair loss. This supports a targeted iron strategy after confirming ongoing losses (menses, GI) and ruling out malabsorption drivers.

Minerals

• Zinc: 65 with Zn/Cu ratio 0.71 (low)

Interpretation:

Low zinc status can impact immune balance, gut barrier function, and hair integrity. Repletion should be time-limited and monitored, with consideration of copper balance

Additional clinical suspicion (based on symptom pattern)

• SIBO or IMO (constipation alternating with loose stool, bloating after high-fiber meals, vegan high-fermentable substrate exposure)
• Dysbiosis with immune activation (eosinophils 7%)

Genetics and Methylation (high-yield summary)

• MTHFR C677T: homozygous (+/+)
• Multiple heterozygous variants impacting methylation pathway resilience

Interpretation:

Genetics do not create a diagnosis, but they can lower physiologic buffer. When intake is limited (vegan diet without consistent B12) and absorption is compromised (gut dysfunction, possible SIBO), the clinical threshold for deficiency is reached faster, and homocysteine can rise more dramatically.

CBC and Immune Pattern

• WBC: 3.6 (low end)
• Eosinophils: 7% (elevated)

Interpretation:

This pattern increases suspicion for allergy-driven inflammation, parasitic exposure (depending on risk), or gut dysbiosis with immune activation. It also supports deeper GI evaluation if symptoms persist.

Clinical Assessment

P.M.’s presentation is most consistent with:

1. Functional B12 deficiency with functional anemia, driven by vegan diet pattern and likely compounded by malabsorption or bacterial overgrowth
2. Likely functional folate insufficiency, supported by elevated FIGLU and MTHFR C677T +/+
3. Severe vitamin D deficiency contributing to immune dysregulation, fatigue, and hair cycling disruption
4. Suboptimal iron stores relevant to hair loss and fatigue, with need to identify ongoing losses and absorption barriers
5. High probability dysbiosis and SIBO or IMO, contributing to nutrient depletion, bowel irregularity, and inflammatory signaling
6. Autoimmune signaling (alopecia areata), warranting thyroid and celiac screening, and a gut-immune approach.

**For this patient, pernicious anemia markers were normal/negative**

Intervention Strategy

Nutrition Plan

Primary objectives: stabilize digestion, reduce fermentable burden if SIBO suspected, rebuild nutrient density, and support protein adequacy.

• Protein target individualized (often 1.2 g/kg/day as a starting clinical anchor if tolerated)
• If remaining vegan:
  • structured daily B12 commitment (non-negotiable)
  • emphasize lower-fermentable protein sources during symptom flare (firm tofu, tempeh in small doses if tolerated, pea or rice protein)
  • strategic use of tolerated cooked vegetables, not raw crucifers as a default
• If open to reintroducing animal foods:
  • High quality animal protein like pasture raised or regenerative eggs, dairy (if tolerated), or wild caught fish can accelerate repletion of B12, iron, zinc, and protein. If open, encourage high quality red meats as well.

GI symptom modulation (temporary, 2 to 6 weeks):

• lower FODMAP style pattern or reduced fermentable fibers
• gradual reintroduction once overgrowth is treated and motility stabilizes

Gut Support (with explicit SIBO consideration)

Because SIBO can contribute to B12 deficiency and perpetuate dysbiosis, the plan was staged:

1. Confirm with breath testing (include methane)
2. Treat based on pattern:
   • Hydrogen-predominant
   • Methane/IMO
3. Motility support (especially constipation-predominant)
4. Rebuild
   • Selective probiotic strategy, avoid aggressive prebiotics early if SIBO is active
   • Reintroduce fibers slowly, titrate to tolerance

Supplement Protocol (initial 8 to 12 weeks, then reassess)

B12 repletion

• Prefer hydroxocobalamin or methylcobalamin, choose based on tolerance
• If neurologic symptoms, autoimmunity or MMA markedly elevated: consider IM injections short term
• Preference for sublingual high-dose to bypass malabsorption issues and get levels up. 

Folate support (after B12 is started)

• 5-MTHF low dose, titrate (especially with COMT sensitivity)
• Add riboflavin (B2) as a supportive cofactor for MTHFR

Vitamin D

• Repletion dosing individualized, paired with magnesium glycinate. 
• Goal: dosing 10,000 IU vitamin D with K daily for 4 weeks, then reduce down to 5,000 IU daily. 
• Follow-up 25-OH D in 8 to 12 weeks, target typically 40 to 60 ng/mL

Iron

• Confirm ongoing need with repeat ferritin and iron indices
• Consider alternate-day dosing for tolerance and absorption
• Evaluate menstrual and GI contributors before long-term continuation

Zinc

• 15 to 30 mg daily with food for 8 to 12 weeks, then reassess Zn/Cu balance

Additional methylation supports (as indicated by symptoms and follow-up labs)

• P5P (B6) cautiously if homocysteine remains elevated
• Trimethylglycine (TMG) or choline support if needed, introduced slowly

Lifestyle and Behavioral Interventions

Stress regulation

• Short daily downshifts (breathing, mindfulness, restorative yoga) to support vagal tone and motility
• Gentle post-meal walks to support glucose handling and gut motility

Sleep optimization

• Consistent sleep and wake times
• Morning light exposure
• Avoid late-night high-fiber meals during gut treatment phase

Movement

• Resistance training continued if tolerated
• Walking prioritized for motility support
• Avoid excessive HIIT during severe deficiency repletion if fatigue is pronounced

Nutrition transition: a 3-phase approach (treat, replete, sustain)

A key inflection point in P.M.’s progress was her decision to transition from strict vegan eating to a more nutrient-dense pattern that included animal protein. This was not framed as a philosophical win or loss, it was positioned as a clinical intervention based on objective deficiency markers, symptoms, and a clear need for reliable B12, iron, zinc, and complete protein intake. With support and education, she found a middle ground that aligned with her values and her physiology, and she reported feeling substantially better.

Phase 1: Stabilize and calm the gut (treat)

• Temporarily reduced high-fermentable fibers that were amplifying bloating and bowel irregularity
• Chose gentler, lower-residue meals and focused on symptom stability and motility support
• Introduced animal protein in small, tolerable amounts (for example, eggs or fish) to reduce reliance on very high-fiber vegan staples during an active GI flare
• The goal was digestive calm and consistency, not dietary perfection

Phase 2: Rebuild nutrient sufficiency (replete)

• Increased nutrient density intentionally, prioritizing:
  • Reliable B12 exposure (food plus therapeutic repletion)
  • Heme and non-heme iron strategies with improved absorption
  • Zinc and protein adequacy to support immune balance and hair cycling
• Built meals around a “protein anchor” first, then added tolerated carbohydrates and cooked vegetables
• This phase emphasized lab-guided dosing and retesting to confirm repletion

Phase 3: Long-term sustainability (maintain)

• Once symptoms stabilized and labs improved, the plan shifted to a sustainable rhythm that felt good to her:
  • A flexible “mostly plant-forward” base
  • Consistent inclusion of animal protein in a frequency and portion size she was comfortable with
  • Ongoing B12 strategy (often still needed long-term depending on intake and absorption)
  • Fiber diversity reintroduced gradually to support the microbiome without triggering relapse
• The clinical aim was long-term adherence with stable digestion, stable energy, and durable nutrient sufficiency

This three-part structure kept the plan realistic and patient-centered: reduce gut burden first, correct deficiencies next, then design a maintenance pattern she could sustain without sliding back into depletion.

Clinical Outcomes 

Short-Term (6 to 10 Weeks)

• Improved energy and reduced brain fog after B12 and vitamin D repletion
• Bloating reduced, bowel regularity improved with motility support
• Hair shedding slowed (regrowth lag expected)
• Homocysteine began trending down with coordinated B12 and folate support

Medium-Term (3 to 6 Months)

• Serum MMA normalized or significantly improved
• Vitamin D improved into target range
• Ferritin increased into a more hair-supportive range
• SIBO treated: breath test improved or normalized, symptom relapse prevention plan established

Closing thoughts

P.M.’s case highlights a frequent clinical trap, serum B12 can appear “acceptable” while intracellular markers and symptom patterns clearly indicate deficiency. In the context of vegan dietary intake, chronic GI symptoms, autoimmune-pattern hair loss, and methylation genetics, functional B12 and folate insufficiency become predictable, not mysterious. Durable improvement required a two-part strategy: rapid correction of foundational nutrient deficits (B12, folate, vitamin D, iron, zinc) and a root-cause gut plan that addressed suspected SIBO or dysbiosis and restored motility and absorption, while also adjusting her diet and daily routines to support her health needs. For many patients, the most meaningful clinical turning points occur when we stop chasing isolated symptoms and instead treat the physiology that connects gut function, immune signaling, and nutrient sufficiency.